Table of Contents 1 Study Coverage 1.1 Sexually Transmitted Diseases (STDs) Drug Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Type 1.4.2 Chlamydia 1.4.3 Gonorrhea 1.4.4 Syphilis 1.4.5 Genital herpes 1.4.6 HPV 1.4.7 HIV / AIDS 1.5 Market by Application 1.5.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size 2.1.1 Global Sexually Transmitted Diseases (STDs) Drug Revenue 2016-2025 2.1.2 Global Sexually Transmitted Diseases (STDs) Drug Sales 2016-2025 2.2 Sexually Transmitted Diseases (STDs) Drug Growth Rate by Regions 2.2.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Regions 2.2.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers 3.1.1 Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers 3.1.2 Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Manufacturers 3.1.3 Global Sexually Transmitted Diseases (STDs) Drug Market Concentration Ratio (CR5 and HHI) 3.2 Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers 3.2.1 Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers (2016-2018) 3.2.2 Sexually Transmitted Diseases (STDs) Drug Revenue Share by Manufacturers (2016-2018) 3.3 Sexually Transmitted Diseases (STDs) Drug Price by Manufacturers 3.4 Sexually Transmitted Diseases (STDs) Drug Manufacturing Base Distribution, Product Types 3.4.1 Sexually Transmitted Diseases (STDs) Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Category 3.4.3 Date of International Manufacturers Enter into Sexually Transmitted Diseases (STDs) Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Type 4.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Type 4.3 Sexually Transmitted Diseases (STDs) Drug Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Application 6 North America 6.1 North America Sexually Transmitted Diseases (STDs) Drug by Countries 6.1.1 North America Sexually Transmitted Diseases (STDs) Drug Sales by Countries 6.1.2 North America Sexually Transmitted Diseases (STDs) Drug Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Sexually Transmitted Diseases (STDs) Drug by Type 6.3 North America Sexually Transmitted Diseases (STDs) Drug by Application 6.4 North America Sexually Transmitted Diseases (STDs) Drug by Company 7 Europe 7.1 Europe Sexually Transmitted Diseases (STDs) Drug by Countries 7.1.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales by Countries 7.1.2 Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Sexually Transmitted Diseases (STDs) Drug by Type 7.3 Europe Sexually Transmitted Diseases (STDs) Drug by Application 7.4 Europe Sexually Transmitted Diseases (STDs) Drug by Company 8 Asia Pacific 8.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug by Countries 8.1.1 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Countries 8.1.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Sexually Transmitted Diseases (STDs) Drug by Type 8.3 Asia Pacific Sexually Transmitted Diseases (STDs) Drug by Application 8.4 Asia Pacific Sexually Transmitted Diseases (STDs) Drug by Company 9 Central & South America 9.1 Central & South America Sexually Transmitted Diseases (STDs) Drug by Countries 9.1.1 Central & South America Sexually Transmitted Diseases (STDs) Drug Sales by Countries 9.1.2 Central & South America Sexually Transmitted Diseases (STDs) Drug Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Sexually Transmitted Diseases (STDs) Drug by Type 9.3 Central & South America Sexually Transmitted Diseases (STDs) Drug by Application 9.4 Central & South America Sexually Transmitted Diseases (STDs) Drug by Company 10 Middle East and Africa 10.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug by Countries 10.1.1 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Countries 10.1.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug by Type 10.3 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug by Application 10.4 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug by Company 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.1.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.1.5 Recent Development 11.2 Hoffmann La Roche 11.2.1 Hoffmann La Roche Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.2.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.2.5 Recent Development 11.3 Bayer Healthcare 11.3.1 Bayer Healthcare Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.3.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.3.5 Recent Development 11.4 Eli Lilly 11.4.1 Eli Lilly Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.4.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.4.5 Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.5.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.5.5 Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.6.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.6.5 Recent Development 11.7 AbbVie, Inc. 11.7.1 AbbVie, Inc. Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.7.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.7.5 Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.8.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.8.5 Recent Development 11.9 GlaxoSmithKline Plc 11.9.1 GlaxoSmithKline Plc Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.9.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.9.5 Recent Development 11.10 Merck & Co., Inc. 11.10.1 Merck & Co., Inc. Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Sexually Transmitted Diseases (STDs) Drug 11.10.4 Sexually Transmitted Diseases (STDs) Drug Product Description 11.10.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Sexually Transmitted Diseases (STDs) Drug Raw Material 13.1.2 Sexually Transmitted Diseases (STDs) Drug Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

List of Tables and Figures Figure Picture of Sexually Transmitted Diseases (STDs) Drug Figure Global Sexually Transmitted Diseases (STDs) Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Sexually Transmitted Diseases (STDs) Drug Production Market Share by Types (Product Category) in 2017 Figure Chlamydia Product Picture Table Major Manufacturers of Chlamydia Figure Gonorrhea Product Picture Table Major Manufacturers of Gonorrhea Figure Syphilis Product Picture Table Major Manufacturers of Syphilis Figure Genital herpes Product Picture Table Major Manufacturers of Genital herpes Figure HPV Product Picture Table Major Manufacturers of HPV Figure HIV / AIDS Product Picture Table Major Manufacturers of HIV / AIDS Table Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Application 2018-2025 (K Units) Figure Hospital Pharmacies Figure Retail Pharmacies Figure Online Pharmacies Figure Sexually Transmitted Diseases (STDs) Drug Report Years Considered Figure Global Sexually Transmitted Diseases (STDs) Drug Market Size 2016-2025 (Million US$) Figure Global Sexually Transmitted Diseases (STDs) Drug Sales 2016-2025 (K Units) Table Global Sexually Transmitted Diseases (STDs) Drug Market Size by Regions 2016-2025 (K Units) & (Million US$) Table Global Sexually Transmitted Diseases (STDs) Drug Sales by Regions 2016-2025 (K Units) Table Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Regions 2016-2025 Figure Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Regions 2016-2025 Figure 2017 Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Regions Table Global Sexually Transmitted Diseases (STDs) Drug Revenue by Regions 2016-2025 (Million US$) Table Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Regions 2016-2025 Figure Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Regions 2016-2025 Figure 2017 Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Regions Table Global Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers (2016-2018) (K Units) Table Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Manufacturers (2016-2018) Figure Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Manufacturers in 2017 Table Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers (2016-2018) (Million US$) Table Sexually Transmitted Diseases (STDs) Drug Revenue Share by Manufacturers (2016-2018) Figure Sexually Transmitted Diseases (STDs) Drug Value Share by Manufacturers in 2017 Table Global Sexually Transmitted Diseases (STDs) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Sexually Transmitted Diseases (STDs) Drug Price (2016-2018) (USD/Unit) Table Sexually Transmitted Diseases (STDs) Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Category Table Date of International Manufacturers Enter into Sexually Transmitted Diseases (STDs) Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Type (2016-2025) Figure Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type in 2017 Table Global Sexually Transmitted Diseases (STDs) Drug Revenue by Type (2016-2025) (Million US$) Table Global Sexually Transmitted Diseases (STDs) Drug Revenue Share by Type (2016-2025) Figure Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type (2016-2025) Figure Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type in 2017 Table Sexually Transmitted Diseases (STDs) Drug Price by Type 2013-2018 (USD/Unit) Table Global Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table Global Sexually Transmitted Diseases (STDs) Drug Sales Share by Application (2016-2025) Figure Global Sales Sexually Transmitted Diseases (STDs) Drug Market Share by Application (2016-2025) Figure Global Sales Sexually Transmitted Diseases (STDs) Drug Market Share by Application (2016-2025) Figure North America Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate 2016-2025 (K Units) Figure North America Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate 2016-2025 (Million US$) Table North America Sexually Transmitted Diseases (STDs) Drug Sales by Countries (2016-2025) (K Units) Table North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries (2016-2025) Figure 2017 North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries Table North America Sexually Transmitted Diseases (STDs) Drug Revenue by Countries (2016-2025) (Million US$) Table North America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries (2016-2025) Figure 2017 North America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries Figure United States Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure United States Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Canada Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Mexico Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Table North America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure 2017 North America Sexually Transmitted Diseases (STDs) Drug Market Share by Type Table North America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2016-2025) Figure 2017 North America Sexually Transmitted Diseases (STDs) Drug Market Share by Application Table North America Sexually Transmitted Diseases (STDs) Drug Sales by Company (2016-2018) (K Units) Table North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company (2016-2018) Figure North America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company in 2017 Figure Europe Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate 2016-2025 (K Units) Figure Europe Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate 2016-2025 (Million US$) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales by Countries (2016-2025) (K Units) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries (2016-2025) Figure 2017 Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries Table Europe Sexually Transmitted Diseases (STDs) Drug Revenue by Countries (2016-2025) (Million US$) Table Europe Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries Figure Germany Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Germany Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (K Units) Figure France Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure France Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (K Units) Figure UK Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure UK Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Italy Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Russia Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure 2017 Europe Sexually Transmitted Diseases (STDs) Drug Market Share by Type Table Europe Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2016-2025) Figure 2017 Europe Sexually Transmitted Diseases (STDs) Drug Market Share by Application Table Europe Sexually Transmitted Diseases (STDs) Drug Sales by Company (2016-2018) (K Units) Table Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company (2016-2018) Figure Europe Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company in 2017 Figure Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate 2016-2025 (K Units) Figure Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Countries (2016-2025) (K Units) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries Figure China Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure China Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Japan Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Korea Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure India Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure India Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Australia Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Indonesia Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Malaysia Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Philippines Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Thailand Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Vietnam Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Singapore Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Market Share by Type Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Sexually Transmitted Diseases (STDs) Drug Market Share by Application Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales by Company (2016-2018) (K Units) Table Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company (2016-2018) Figure Asia Pacific Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company in 2017 Figure Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate 2016-2025 (K Units) Figure Central & South America Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales by Countries (2016-2025) (K Units) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries Table Central & South America Sexually Transmitted Diseases (STDs) Drug Revenue by Countries (2016-2025) (Million US$) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries Figure Brazil Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Brazil Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Argentina Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Sexually Transmitted Diseases (STDs) Drug Market Share by Type Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Sexually Transmitted Diseases (STDs) Drug Market Share by Application Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales by Company (2016-2018) (K Units) Table Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company (2016-2018) Figure Central & South America Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company in 2017 Figure Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate 2016-2025 (K Units) Figure Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Countries (2016-2025) (K Units) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Countries Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Countries Figure GCC Countries Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure GCC Countries Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Turkey Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure Egypt Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (2016-2025) (K Units) Figure South Africa Sexually Transmitted Diseases (STDs) Drug Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Type (2016-2025) (K Units) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Market Share by Type Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Application (2016-2025) (K Units) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Market Share by Application Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales by Company (2016-2018) (K Units) Table Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company (2016-2018) Figure Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Company in 2017 Table Pfizer Company Details Table Pfizer Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Pfizer Recent Development Table Hoffmann La Roche Company Details Table Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Hoffmann La Roche Recent Development Table Bayer Healthcare Company Details Table Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Bayer Healthcare Recent Development Table Eli Lilly Company Details Table Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Eli Lilly Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Johnson & Johnson Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Bristol-Myers Squibb Recent Development Table AbbVie, Inc. Company Details Table AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table AbbVie, Inc. Recent Development Table Gilead Sciences Company Details Table Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Gilead Sciences Recent Development Table GlaxoSmithKline Plc Company Details Table GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table GlaxoSmithKline Plc Recent Development Table Merck & Co., Inc. Company Details Table Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Merck & Co., Inc. Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Sexually Transmitted Diseases (STDs) Drug Value Chain Table Typical Suppliers of Key Sexually Transmitted Diseases (STDs) Drug Raw Material Table Sexually Transmitted Diseases (STDs) Drug Customers List Table Sexually Transmitted Diseases (STDs) Drug Sales Channels Table Sexually Transmitted Diseases (STDs) Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources